Format
Sort by

Send to

Choose Destination

Selected items

Items: 5

1.

Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.

Saxena SK, Shrivastava G, Tiwari S, Swamy MA, Nair MP.

Future Virol. 2012 Jun 1;7(6):609-620.

2.

HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux.

Cui HL, Grant A, Mukhamedova N, Pushkarsky T, Jennelle L, Dubrovsky L, Gaus K, Fitzgerald ML, Sviridov D, Bukrinsky M.

J Lipid Res. 2012 Apr;53(4):696-708. doi: 10.1194/jlr.M023119. Epub 2012 Jan 19.

3.

Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation.

Mujawar Z, Tamehiro N, Grant A, Sviridov D, Bukrinsky M, Fitzgerald ML.

Biochemistry. 2010 Sep 28;49(38):8338-49. doi: 10.1021/bi100466q.

4.

Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1.

Morrow MP, Grant A, Mujawar Z, Dubrovsky L, Pushkarsky T, Kiselyeva Y, Jennelle L, Mukhamedova N, Remaley AT, Kashanchi F, Sviridov D, Bukrinsky M.

Mol Pharmacol. 2010 Aug;78(2):215-25. doi: 10.1124/mol.110.065029. Epub 2010 May 17.

5.

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, Mukhamedova N, Fu Y, Dart A, Orenstein JM, Bobryshev YV, Bukrinsky M, Sviridov D.

PLoS Biol. 2006 Oct;4(11):e365.

Supplemental Content

Support Center